266 related articles for article (PubMed ID: 26410102)
61. Allogeneic hematopoietic stem cell transplantation for pediatric acute lymphoblastic leukemia.
Tian J; Wei A; Wang B; Yang J; Zheng H; Qin M
Ann Hematol; 2024 Jan; 103(1):297-305. PubMed ID: 37991510
[TBL] [Abstract][Full Text] [Related]
62. Acute lymphoblastic leukemia in infants: A quarter century of nationwide efforts in Japan.
Tomizawa D; Miyamura T; Koh K; Ishii E
Pediatr Int; 2022 Jan; 64(1):e14935. PubMed ID: 34324764
[TBL] [Abstract][Full Text] [Related]
63. Keep in Mind Quality of Life: Outcome of a Ten-Year Series of Post-Transplantation Early Relapses in Childhood Acute Lymphoblastic Leukemia-A Report from the Grand Ouest Oncology Study Group for Children in France.
Haro S; Tavenard A; Rialland F; Taque S; Guillerm G; Blouin P; Esvan M; Pellier I; Gandemer V
Biol Blood Marrow Transplant; 2016 May; 22(5):889-94. PubMed ID: 26845034
[TBL] [Abstract][Full Text] [Related]
64. Azacitidine successfully maintained the second remission in an infant with KMT2A-rearranged acute lymphoblastic leukemia who relapsed after unrelated cord blood transplantation.
Chijimatsu I; Imanaka Y; Tomizawa D; Eguchi M; Nishimura S; Karakawa S; Miki M; Hamamoto K; Fujita N
Pediatr Blood Cancer; 2017 Dec; 64(12):. PubMed ID: 28675638
[TBL] [Abstract][Full Text] [Related]
65. CDKN1A-mediated responsiveness of MLL-AF4-positive acute lymphoblastic leukemia to Aurora kinase-A inhibitors.
Chen YP; Lin HJ; Chen JS; Tsai MY; Hsieh HP; Chang JY; Chen NF; Chang KC; Huang WT; Su WC; Yang ST; Chang WC; Hung LY; Chen TY
Int J Cancer; 2014 Aug; 135(3):751-62. PubMed ID: 24382688
[TBL] [Abstract][Full Text] [Related]
66. Bimodal distribution of genomic MLL breakpoints in infant acute lymphoblastic leukemia treatment.
Jung R; Jacobs U; Krumbholz M; Langer T; Keller T; De Lorenzo P; Valsecchi MG; van der Velden VH; Moericke A; Stanulla M; Teigler-Schlegel A; Panzer-Gruemayer ER; van Dongen JJ; Schrappe M; den Boer ML; Pieters R; Rascher W; Metzler M
Leukemia; 2010 Apr; 24(4):903-7. PubMed ID: 20164851
[No Abstract] [Full Text] [Related]
67. Allogeneic hematopoietic stem cell transplantation improves the prognosis of p16-deleted adult patients with acute lymphoblastic leukemia.
Wang Y; Chen G; Cao R; Li J; He L; Guo X; Liang J; Shi P; Zhou Y; Xu B
Pharmacogenomics; 2017 Jan; 18(1):77-84. PubMed ID: 27967319
[TBL] [Abstract][Full Text] [Related]
68. Unraveling the cellular origin and clinical prognostic markers of infant B-cell acute lymphoblastic leukemia using genome-wide analysis.
Agraz-Doblas A; Bueno C; Bashford-Rogers R; Roy A; Schneider P; Bardini M; Ballerini P; Cazzaniga G; Moreno T; Revilla C; Gut M; Valsecchi MG; Roberts I; Pieters R; De Lorenzo P; Varela I; Menendez P; Stam RW
Haematologica; 2019 Jun; 104(6):1176-1188. PubMed ID: 30679323
[TBL] [Abstract][Full Text] [Related]
69. Identification of co-expressed genes associated with MLL rearrangement in pediatric acute lymphoblastic leukemia.
Zhang H; Liu B; Cheng J; Ma H; Li Z; Xi Y
Biosci Rep; 2020 May; 40(5):. PubMed ID: 32347296
[TBL] [Abstract][Full Text] [Related]
70. MicroRNA-142-3p inhibits cell proliferation in human acute lymphoblastic leukemia by targeting the MLL-AF4 oncogene.
Dou L; Li J; Zheng D; Li Y; Gao X; Xu C; Gao L; Wang L; Yu L
Mol Biol Rep; 2013 Dec; 40(12):6811-9. PubMed ID: 24057258
[TBL] [Abstract][Full Text] [Related]
71. A Novel t(4;11)(q21;q23) MLL-AF4 fusion transcript in infant leukemia.
Abdelhaleem M; Yi Q; Beimnet K; Grant R
Am J Hematol; 2007 Mar; 82(3):247. PubMed ID: 16924642
[No Abstract] [Full Text] [Related]
72. Nuclear FGFR2 Interacts with the MLL-AF4 Oncogenic Chimera and Positively Regulates
Fioretti T; Cevenini A; Zanobio M; Raia M; Sarnataro D; Cattaneo F; Ammendola R; Esposito G
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33924850
[TBL] [Abstract][Full Text] [Related]
73. [Imatinib in combination with allogeneic hematopoietic stem cell transplantation improved the outcome of adult Philadelphia chromosome-positive acute lymphoblastic leukemia].
Cheng Z; Zhao L; Chen G; Wu D; Qiu H; Tang X; Fu C; Jin Z; Chen F; Xue S; Sun A
Zhonghua Xue Ye Xue Za Zhi; 2014 Feb; 35(2):114-9. PubMed ID: 24606651
[TBL] [Abstract][Full Text] [Related]
74. Outcome of hematopoietic stem cell transplantation of children with very high risk acute lymphoblastic leukemia in first complete remission.
Schechter T; Ishaqi KM; Rojas M; Irina Z; Doyle JJ; Gassas A
Pediatr Transplant; 2010 May; 14(3):377-82. PubMed ID: 19793223
[TBL] [Abstract][Full Text] [Related]
75. AAV8 vector expressing IL24 efficiently suppresses tumor growth mediated by specific mechanisms in MLL/AF4-positive ALL model mice.
Tamai H; Miyake K; Yamaguchi H; Takatori M; Dan K; Inokuchi K; Shimada T
Blood; 2012 Jan; 119(1):64-71. PubMed ID: 22025528
[TBL] [Abstract][Full Text] [Related]
76. A risk-stratified therapy for infants with acute lymphoblastic leukemia: a report from the JPLSG MLL-10 trial.
Tomizawa D; Miyamura T; Imamura T; Watanabe T; Moriya Saito A; Ogawa A; Takahashi Y; Hirayama M; Taki T; Deguchi T; Hori T; Sanada M; Ohmori S; Haba M; Iguchi A; Arakawa Y; Koga Y; Manabe A; Horibe K; Ishii E; Koh K
Blood; 2020 Oct; 136(16):1813-1823. PubMed ID: 32845001
[TBL] [Abstract][Full Text] [Related]
77. Mature B-cell acute lymphoblastic leukaemia associated with a rare MLL-FOXO4 fusion gene.
Lim L; Chen KS; Krishnan S; Gole L; Ariffin H
Br J Haematol; 2012 Jun; 157(6):651. PubMed ID: 22429121
[No Abstract] [Full Text] [Related]
78. MLL fusion-driven activation of CDK6 potentiates proliferation in MLL-rearranged infant ALL.
van der Linden MH; Willekes M; van Roon E; Seslija L; Schneider P; Pieters R; Stam RW
Cell Cycle; 2014; 13(5):834-44. PubMed ID: 24736461
[TBL] [Abstract][Full Text] [Related]
79. Outcome of pediatric acute lymphoblastic leukemia with very late relapse: a retrospective analysis by the Tokyo Children's Cancer Study Group (TCCSG).
Kato M; Manabe A; Saito AM; Koh K; Inukai T; Ogawa C; Goto H; Tsuchida M; Ohara A
Int J Hematol; 2015 Jan; 101(1):52-7. PubMed ID: 25432437
[TBL] [Abstract][Full Text] [Related]
80. FLT3 activation cooperates with MLL-AF4 fusion protein to abrogate the hematopoietic specification of human ESCs.
Bueno C; Ayllón V; Montes R; Navarro-Montero O; Ramos-Mejia V; Real PJ; Romero-Moya D; Araúzo-Bravo MJ; Menendez P
Blood; 2013 May; 121(19):3867-78, S1-3. PubMed ID: 23479570
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
